Arkolith/Insider Trading/COGT/Form 4

Fairmount Funds Management LLC

DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Apr 1, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Other(J)287K——4.7M
Mar 28, 2024Other(J)287K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 28, 2024Other(J)12K—$067K
Mar 28, 2024Other(J)12K—$00

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-039588) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML